News & Press

FDA Approves Foundation Medicine’s FoundationOne Liquid CDx, a Comprehensive Pan-Tumor Liquid Biopsy Test

August 28, 2020

Washington, DC, August 28, 2020 – This week, the U.S. Food and Drug Administration (FDA) approved Foundation Medicine, Inc.’s comprehensive pan-tumor liquid biopsy test called FoundationOne Liquid CDx. This test analyzes more than 300 genes and genomic …

FDA Approves Atezolizumab to Treat BRAF V600 Unresectable or Metastatic Melanoma

July 31, 2020

Washington, DC, July 31, 2020 – On July 30, 2020, the Food and Drug Administration approved atezolizumab (Tecentriq, Genentech, Inc.) in combination with cobimetinib and vemurafenib for the treatment of patients with BRAF V600 mutation-positive unresec …

House Appropriations Committee Includes $20 million for Defense-funded Melanoma Research

July 21, 2020

Washington, DC, July 21, 2020 – The Melanoma Research Foundation (MRF) commends the House Appropriations Committee for including $20 million for Department of Defense (DoD)-funded melanoma research in its Fiscal 2021 Department of Defense Appropriation …

House Appropriations Committee Approves Funding for Fiscal 2021 Labor, Health and Human Services Bill

July 13, 2020

Washington, DC, July 13, 2020 – Today the House Appropriations Committee approved its version of the Fiscal 2021 Labor, Health and Human Services (LHHS) Appropriations bill. The House bill provides $47 billion for the National Institutes of Health (NIH …

Meet the Honoree: Dr. Stephanie Frankel

July 9, 2020

Meet Dr. Stephanie Frankel! This year the MRF is honoring Dr. Frankel with the Humanitarian Award at our 2020 Denver Virtual Gala on August 6th! Get to know more about her below!  After growing up in Denver, Dr. Frankel attended Yale University where s …